首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性乙型重症肝炎及肝癌与血清可溶性Fas可溶性Fas配体 …
引用本文:宋卫青,吕维红.慢性乙型重症肝炎及肝癌与血清可溶性Fas可溶性Fas配体 …[J].中华检验医学杂志,2000,23(4):223-225.
作者姓名:宋卫青  吕维红
作者单位:青岛市市立医院
摘    要:目的 探讨血清可溶性Fas/可溶性Fas配体水平与慢性乙型重症肝炎以及乙肝病毒相关性肝细胞癌变之间的关系。方法 用酶联免疫吸附双抗体夹心法检测21例无症状乙肝病毒携带者,20例慢性乙型重症肝炎及22例乙肝病毒相关性肝细胞癌患者血清sFas、sFasL水平。结果 与无症状乙肝病毒携带者比较,慢性乙肝重症肝炎患者血清sFas、sFasL水平均增高,其差异有显著意义;乙肝病毒相关性肝细胞癌患者sFas水

关 键 词:可溶性Fas  可溶性Fas配体  慢性乙型肝炎  肝肿瘤
修稿时间:1999-12-08

Ralationship between serum soluble Fas/soluble Fas ligand and chronic serious hepatitis B/hepotocellular carcinoma
SONG Weiqing,LU Weihong,HOU Wei,et al..Ralationship between serum soluble Fas/soluble Fas ligand and chronic serious hepatitis B/hepotocellular carcinoma[J].Chinese Journal of Laboratory Medicine,2000,23(4):223-225.
Authors:SONG Weiqing  LU Weihong  HOU Wei  
Institution:SONG Weiqing,LU Weihong,HOU Wei,et al. Qingdao Municipal Hospital,Qingdao 266011,China
Abstract:Objective To study the relationship between soluble Fas/soluble Fas Ligand levels in serum and chronic serious hepatitis B/ hepotocellular carcinoma.Methods Soluble Fas (sFas) and soluble Fas Ligand (sFasL) levels in serum were measured in 21 patients with asymptomatic HBsAg carriers ,20 patients with chronic serious hepatitis B, and 22 patients with hepotocellular carcinoma by enzyme Linked immunosorbent assay (ELISA).Results Compared with asymptomatic HBsAg carriers, the sFas and sFasL levels in serum of patients with chronic serious hepatitis B were both significantly increased ( P <0.01) the sFas level was significantly increased, whereas the sFasL level being decreased.Conclusion There was significant relationship between sFas/sFasL levels and chronic serious hepatitis B/hepotocellular carcinoma.
Keywords:Soluble Fas  Soluble Fas ligand  Chronic serious hepatitis B
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号